These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiovascular effects of dopamine in the anaesthetized dog. Sampson RG; Scroop GC; Louis WJ Clin Exp Pharmacol Physiol; 1974; 1(1):3-12. PubMed ID: 4457265 [No Abstract] [Full Text] [Related]
3. [Mechanism of the antihypertensive action of propranolol]. Magnani B; Ambrosioni E; Branzi A; Maresta A; Picchio F; Russo F; Sanguinetti M Minerva Cardioangiol; 1973 Apr; 21(4):284-97. PubMed ID: 4710125 [No Abstract] [Full Text] [Related]
4. Neurogenic maintenance of peripheral resistance in borderline hypertension. Julius S; Esler M; Randall OS; Ellis C Acta Physiol Lat Am; 1974; 24(5):425-31. PubMed ID: 4467668 [No Abstract] [Full Text] [Related]
5. [The effects of inotropic substances on the heart dynamics and peripheral blood circulation]. Schüren KP; Buschmann J; Meyer V; Schröder R Verh Dtsch Ges Kreislaufforsch; 1968; 34():206-13. PubMed ID: 4899541 [No Abstract] [Full Text] [Related]
6. Glucagon: its mechanism of action on the coronary circulation in the conscious dog. Terry B; White FC; Bloor CM Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531 [No Abstract] [Full Text] [Related]
7. Hemodynamic studies on hypertension. II. Effects of isoproterenol, propranolol, noradrenaline and phentolamine on the hemodynamics in essential hypertension. Tsuchiya M Jpn Circ J; 1972 Mar; 36(3):275-88. PubMed ID: 5068095 [No Abstract] [Full Text] [Related]
8. Influence of phentolamine on the cardiovascular effects of dopamine in experimental cardiogenic shock. Bagwell EE; Daniell HB; Freeman BF Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):197-203. PubMed ID: 4852444 [No Abstract] [Full Text] [Related]
9. Cardiac actions of oxprenolol as studied in dog heart-lung preparations. Takeda K; Iizuka H; Imai S Arzneimittelforschung; 1973 Oct; 23(10):1446-50. PubMed ID: 4149692 [No Abstract] [Full Text] [Related]
10. [Changes in cardiac output and total peripheral resistance under the influence of anti-adrenergic substances]. Kinin IE; Iuzhakov SO Farmakol Toksikol; 1973; 36(2):238-42. PubMed ID: 4791602 [No Abstract] [Full Text] [Related]
11. Haemodynamic response to exercise after combined sympathetic and parasympathetic blockade of the heart. Nordenfelt I Cardiovasc Res; 1971 Apr; 5(2):215-22. PubMed ID: 5579525 [No Abstract] [Full Text] [Related]
12. Hemodynamic effects of a moderate increase of the plasma vasopressin level in conscious dogs. Szczepańska-Sadowska E Pflugers Arch; 1973; 338(4):313-22. PubMed ID: 4734844 [No Abstract] [Full Text] [Related]
13. Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine. Brunner H; Hedwall PR; Meier M Br J Pharmacol Chemother; 1967 May; 30(1):123-33. PubMed ID: 6039968 [No Abstract] [Full Text] [Related]
14. Actions of bretylium tosylate on the cardiovascular system of the dog. Richmond DR; Angus JA; Goodman AH; Cobbin LB Cardiovasc Res; 1973 Jan; 7(1):47-54. PubMed ID: 4694956 [No Abstract] [Full Text] [Related]
15. Hemodynamic responses to beta-adrenergic blockade in dogs. Shen Y; Quiroz AC; Burch GE; DePasquale NP Am Heart J; 1967 May; 73(5):669-73. PubMed ID: 4225818 [No Abstract] [Full Text] [Related]
16. Cardiovascular effects of 2-pyridine aldoxime methylchloride (pralidoxime and blood pressure). Stavinoha WB; Hinshaw LB; Smith PW; Rieger JA Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):52-65. PubMed ID: 5480142 [No Abstract] [Full Text] [Related]
17. [Effect of obsidan on the systemic hemodynamics of dogs in ontogeny]. Brin VB Farmakol Toksikol; 1977; 40(5):551-6. PubMed ID: 923777 [TBL] [Abstract][Full Text] [Related]
18. Vasodilative effect of hydralazine in awake dogs: the roles of prostaglandins and the sympathetic nervous system. Maekawa K; Liang CS; Tsui A; Chen BT; Kawashima S Circulation; 1984 Nov; 70(5):908-16. PubMed ID: 6488504 [TBL] [Abstract][Full Text] [Related]
19. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade. Szekeres L; Udvary E; Papp JG Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698 [No Abstract] [Full Text] [Related]
20. Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action. Côté P; Polumbo RA; Harrison DC Cardiovasc Res; 1974 Nov; 8(6):721-30. PubMed ID: 4457225 [No Abstract] [Full Text] [Related] [Next] [New Search]